Insys Therapeutics (INSY) Granted FDA Fast Track Designation for Cannabidiol for Prader-Willi Syndrome
Tweet Send to a Friend
INSYS Therapeutics, Inc. (NASDAQ: INSY), announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
